| ²é¿´: 528 | »Ø¸´: 27 | |||
| ¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß ADTechnology µÄ 80 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á | |||
ADTechnology
|
[É̼ҹ©Ó¦]
ø±êÒDzⶨm6A¼×»ù»¯Ã¸µÄ»îÐÔ---m6A¼×»ù»¯Ã¸»îÐÔ/ÒÖÖÆ·ÖÎöÊÔ¼ÁºÐ(±ÈÉ«·¨)-(A-P-9019)
|
||
|
ÏÞÁ¿ x ÕÅ
Âú x ¿ÉʹÓã»ÓÐЧÆÚ x Ì죻¹ýÆÚ¿ÉÍË |
ÄÚÈÝ
m6A¼×»ù»¯Ã¸»îÐÔ/ÒÖÖÆ·ÖÎöÊÔ¼ÁºÐ(±ÈÉ«·¨) »õºÅ£ºA-P-9019Epigenase m6A Methylase Activity/Inhibition Assay Kit (Colorimetric) ±³¾°×ÊÁÏ£ºN6-methyladenosine (m6A) is the most common and abundant modification on RNA molecules present in eukaryotes and also found in prokaryotes and virus. Recently, DNA m6A is also identified in multicellular eukaryotes including Caenorhabditis elegans and Drosophila melanogaster, and furthermore identified in higher eukaryotes including plants, mouse and human cells. m6A plays crucial roles in regulating DNA replication, DNA damage, RNA splicing, transposition, transcription, and cellular defense. In human cells, the m6A modification is catalyzed by the methyltransferases (writers) such as METTL3/14, WTAP, RBM15/15B and KIAA1429, and removed by the ¦Á-ketoglutarate (¦Á-KG)- and Fe2+-dependent demethylases (erasers) such as FTO, ALKBH5 and TET-like enzymes. It was shown that m6A methylases and demethylases play important roles in many biological processes, ranging from development and metabolism to fertility and participate in pathogenesis of multiple diseases including cancers and viral infections. The dynamic and reversible chemical m6A modification on DNA/RNA may also serve as a novel epigenetic marker of profound biological significance. Up-regulation of m6A modification was shown to increase virus replication and promote cancer growth. Down-regulation of m6A modification was first characterized in human cancer cells and tissues, relative to their normal controls¡£ ²úÆ·ÃèÊö£ºThis kit is designed for measuring total m6A methylase activity/inhibition. In an assay with this kit, the unique m6A substrate is stably coated on the strip wells. Active m6A methylases bind to and methylate m6A contained in the substrate. The un-demethylated m6A in the substrate can be recognized with a high affinity m6A antibody and the immuno-signal is enhanced with enhancer solution. The ratio or amount of un-demethylated m6A, which is inversely proportional to enzyme activity, can then be colorimetrically quantified through an ELISA-like reaction¡£ ²úÆ·ÌØµã£º 1¡¤Fast: Colorimetric assay with easy-to-follow steps for convenience and speed. The entire procedure can be finished within 4 hours£» 2¡¤Robust: Innovative kit composition enables background signals to be extremely low and allows the assay to be simple, accurate, reliable, and consistent£» 3.Convenient: Both cell/tissue nuclear extracts and purified proteins can be used, which allows detection of inhibitory effects of m6A methylase inhibitor in vivo and in vitro. 4.Sensitive and Specific: Novel assay principle allows to detect the m6A methylase-converted end product, which makes the assay much more specific than that for by-product measurement. The assay also allows high sensitivity to be achieved. The activity can be detected from as low as 2 ¦Ìg of nuclear extracts or 50 ng of purified enzymes£» 5.Quantitative: The assay standard is included, which allows the specific activity of m6A methylase to be quantified£» 6.Flexible: Strip-well microplate format makes the assay flexible for manual or high throughput analysis¡£ Êý¾Ý·ÖÎö£º ±ê×¼ÇúÏßչʾ ±êÇú·ÖÎö ʹÓÃm6A¼×»ù»¯Ã¸»îÐÔ/ÒÖÖÆ·ÖÎöÊÔ¼ÁºÐ(±ÈÉ«·¨) Õë¶ÔÖØ×éµÄMETTL3/14 Íê³ÉÁËm6A ¼×»ù»¯Ã¸»îÐԵļì²â.ÖØ×éµÄÈËÀàMETTL3/14øÔÚ²»Í¬Å¨¶ÈϵÄÊý¾Ý. ÓÃm6A¼×»ù»¯Ã¸·ÖÎö±ê׼ƷÉú³É±ê×¼ÇúÏß ²Î¿¼ÎÄÏ×£º 1.Lewinska A et. al. (February 2017). Downregulation of Methyltransferase Dnmt2 Results in Condition-dependent Telomere Shortening and Senescence or Apoptosis in Mouse Fibroblasts. J Cell Physiol. ±£´æ½¨Ò飺ÔÚ½ÓÊÕµ½°¬µÂ¼Ä³öµÄÊÔ¼ÁºÐºóÇë°´ÕÕ˵Ã÷Ê齨Ò飬ʹÓò»Í¬µÄ±£´æÌõ¼þ»òζÈÀ´±£´æÊÔ¼ÁºÐÄÚ×é·Ö¡£ ¸ü¶àÄÚÈÝÇë²Î¿¼¹ÙÍø:ÃÍ´Á¿´ÏêÇé ![]() p-9019-09.png |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : A-P-9019-m6A¼×»ù»¯Ã¸»îÐÔÒÖÖÆ·ÖÎöÊÔ¼ÁºÐ£¨±ÈÉ«·¨£©.pdf
2020-06-02 18:39:36, 899.72 K
» ²ÂÄãϲ»¶
271²ÄÁϹ¤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ16È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ìר˶µ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çó²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ£¬080502£¬354·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:
×ø±êÉϺ££¬³ÏÕ÷Å®ÓÑ£¬·Ç³£ ׿±£¬Ë½ÐűػØ
+1/468
ÎïÀíѧ µ÷¼Á
+1/85
¸£½¨Ê¦·¶´óѧÕÐÊÕ2026Ä껯ѧ¡¢²ÄÁÏ˶ʿ3-4Ãû
+1/78
×ø±ê¹ãÖÝ£¬ÄÐÕ÷Å®£¬Ë«Ïò±¼¸°
+1/67
»ªÄÏʦ·¶´óѧ£¨211£©²©Ê¿ÕÐÉú- µç×Ó¡¢×Ô¶¯»¯¡¢»úе¡¢ÉúÎïѧ¡¢ÎïÀíÏà¹Ø×¨Òµ
+2/42
Çൺ´óѧ̩ɽѧÕß¿ÎÌâ×éÕÐ2026ÄêÉêÇ뿼ºËÖÆ²©Ê¿
+1/33
ÖØÇìÎÄÀíѧԺ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ 2026 ½ì˶ʿÑо¿Éúµ÷¼Á֪ͨ
+1/16
ѧÊõ/רҵ˶ʿµ÷¼Á¡ª¡ª»¯Ñ§¡¢×ÊÔ´Óë»·¾³
+1/15
2026ÄêÎ÷ÄϿƼ¼´óѧ¹¦ÄÜÍ¿²ã¿ÎÌâ×é¼ò½é
+1/11
ÄϾ©Ò½¿Æ´óѧ-Ĥµ°°×½á¹¹Ó빦ÄÜ¿ÎÌâ×é-ÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú
+1/11
¡¾²©Ê¿ÕÐÉú¡¿Î人¿Æ¼¼´óѧÕÐÊÕ²ÄÁÏ¡¢»¯¹¤¡¢»·¾³¡¢Ò±½ðÀà2026Äê¡°ÉêÇë-¿¼ºË¡±ÖƲ©Ê¿Éú
+1/8
ÐÂ¼ÓÆÂ¹úÁ¢´óѧҩѧϵ»¯Ñ§ÉúÎïѧ¿ÎÌâ×éÕÐPhD
+1/8
MTI 380µ÷¼Á
+1/8
ÁijǴóѧ»¯ÔºÇཷÕÐÊÕ»¯Ñ§Ïà¹Ø×¨Òµµ÷¼ÁѧÉú
+1/7
Çൺ¿Æ¼¼´óѧ¿É³ÖÐø¸ß·Ö×ÓÍÅ¶Ó ¿¼ÑÐÕÐÉú
+1/7
¹ú¼Ò¼¶È˲ÅÍÅ¶Ó³ÏÆ¸ÉúÎïÐÅÏ¢Ïà¹Ø×¨ÒµµÄ¿ÆÑÐÖúÀí
+1/5
323·Ö¿ØÖƹ¤³ÌÇóµ÷¼Á
+1/2
¸£½¨Ê¦·¶´óѧº£Ï¿ÈáÐÔµç×ÓѧԺÕÐÊÕ2026µ÷¼Á˶ʿ
+1/2
Î÷°²½»Í¨´óѧÉúÃüѧԺÖÇÄÜ»¯ÕïÁÆ×°±¸Ñо¿ÖÐÐÄ2026Ä격ʿÉúÕÐÉú
+1/1
¸£½¨Ê¦·¶´óѧ»·¾³Î¢ÉúÎï¼¼Êõ¿ÎÌâ×é½ÓÊÜ2026¼¶Ë¶Ê¿µ÷¼Á
+1/1
ADTechnology
¾èÖú¹ó±ö (ÖøÃûдÊÖ)
±í¹ÛÒÅ´«Ñ§×¨Òµ¹©Ó¦ÉÌ
- Ó¦Öú: 12 (СѧÉú)
- ½ð±Ò: 12092.7
- É¢½ð: 1762
- ºì»¨: 1
- Ìû×Ó: 2608
- ÔÚÏß: 49.1Сʱ
- ³æºÅ: 1787705
- ×¢²á: 2012-04-30
- רҵ: ÈËÀàÒÅ´«Ñ§

±í¹ÛÒÅ´«Ñ§£¨m6A RNA¼×»ù»¯¡¢RNA¼×»ù»¯¡¢DNA¼×»ù»¯¡¢DNAôǼ׻ù¡¢DNA¼×õ£»ù¡¢DNAôÈ»ù£©£¬·Ö×ÓÉúÎïѧ£¬ÃâÒßÉúÎïѧ£¨Ò»¿¹¡¢¶þ¿¹£©£¬Ï¸°ûÉúÎïѧ£¬ÊµÑéÒÇÆ÷ѧ£¨ºËËáÌáÆðÒÇ¡¢³¬Î¢Á¿·Ö¹â¹â¶È¼Æ£©µÈµÈ²úÆ·Óë¼¼Êõ·þÎñ
±±¾©ÊвýÆ½ÇøÖйشåÉúÃü¿ÆÑ§Ô°¶«60Ã×°¬µÂÔ°
ÁªÏµÈË: Peter Chen / ÓÊÏä: 1951545998@qq.com / QQ: 1513545070 / µç»°: 0313-5935521 / ÊÖ»ú: 18911529660
2Â¥2020-06-02 18:41:32
3Â¥2020-06-02 18:41:38
4Â¥2020-06-02 19:10:41
¡ï
ADTechnology(½ð±Ò+1): лл²ÎÓë
ADTechnology(½ð±Ò+1): лл²ÎÓë
|
5Â¥2020-06-03 09:02:01
6Â¥2020-06-03 11:25:11
¡ï
ADTechnology(½ð±Ò+1): лл²ÎÓë
ADTechnology(½ð±Ò+1): лл²ÎÓë
|
7Â¥2020-06-03 11:34:40
¡ï
ADTechnology(½ð±Ò+1): лл²ÎÓë
ADTechnology(½ð±Ò+1): лл²ÎÓë
|
8Â¥2020-06-03 13:42:21
9Â¥2020-06-03 13:58:07
¡ï
ADTechnology(½ð±Ò+1): лл²ÎÓë
ADTechnology(½ð±Ò+1): лл²ÎÓë
|
10Â¥2020-06-03 16:35:44


m6A¼×»ù»¯Ã¸»îÐÔ/ÒÖÖÆ·ÖÎöÊÔ¼ÁºÐ(±ÈÉ«·¨) »õºÅ£ºA-P-9019
»Ø¸´´ËÂ¥
